\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ surgery\\ and\\ radiation\\ therapy\ \(3\)\
\-\ irregularly\\ enhancing\\ mass\\ in\\ right\\ temporal\\ and\\ frontal\\ lobe\\ with\\ extension\\ into\\ basal\\ ganglia\\.\ \(0\)\
\-\ moderate\\ amount\\ of\\ associated\\ surrounding\\ \\"vasogenic\\ edema\\"\\ and\\ mass\\ effect\\.\ \(0\)\
\-\ glioblastoma\\ multiforme\ \(8\)\
\-\ \\â\\€\\¢\\ abscess\ \(6\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ gbm\\ \\(who\\ gr4\\)\ \(0\)\
\-\ 51\\ y\\.o\\.\\ woman\\ with\\ a\\ three\\ week\\ history\\ of\\ headache\\,\\ nausea\\ and\\ unsteady\\ gait\\.\ \(1\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ gr4\\:\\ 0\\.12495955759087005\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.09643165240590079\ \(0\)\
\-\ unsteady\\:\\ 0\\.0939610495825275\ \(0\)\
\-\ irregularly\\:\\ 0\\.08549879824530794\ \(0\)\
\-\ gbm\\:\\ 0\\.07775874320419901\ \(0\)\
\-\ multiforme\\:\\ 0\\.07639032034240677\ \(0\)\
\-\ glioblastoma\\:\\ 0\\.07237914707374134\ \(0\)\
\-\ 51\\:\\ 0\\.07140201775493632\ \(0\)\
\-\ vasogenic\\:\\ 0\\.07116713356830881\ \(0\)\
\-\ ganglia\\:\\ 0\\.06727487949963357\ \(0\)\
\-\ gait\\:\\ 0\\.06121902333869263\ \(0\)\
\-\ basal\\:\\ 0\\.059931346125205745\ \(0\)\
\-\ amount\\:\\ 0\\.05489991310470788\ \(0\)\
\-\ nausea\\:\\ 0\\.052926769481266664\ \(0\)\
\-\ temporal\\:\\ 0\\.05264447504021749\ \(0\)\
\-\ moderate\\:\\ 0\\.051695343209366106\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.048554403203182724\ \(0\)\
\-\ extension\\:\\ 0\\.046928112633563904\ \(0\)\
\-\ effect\\:\\ 0\\.04654705004721915\ \(0\)\
\-\ headache\\:\\ 0\\.045153622116396896\ \(0\)\
\-\ week\\:\\ 0\\.044646391051203514\ \(0\)\
\-\ three\\:\\ 0\\.0443172958207217\ \(0\)\
\-\ surrounding\\:\\ 0\\.04321792714407331\ \(0\)\
\-\ radiation\\:\\ 0\\.04314232691634364\ \(0\)\
\-\ abscess\\:\\ 0\\.041566711448219495\ \(0\)\
\-\ frontal\\:\\ 0\\.04129679899205165\ \(0\)\
\-\ enhancing\\:\\ 0\\.04123005435207322\ \(0\)\
\-\ y\\.o\\:\\ 0\\.03794429896287231\ \(0\)\
\-\ lymphoma\\:\\ 0\\.037572286682915165\ \(0\)\
\-\ edema\\:\\ 0\\.03718343829894294\ \(0\)\
\-\ mass\\:\\ 0\\.03656803098300199\ \(0\)\
\-\ lobe\\:\\ 0\\.03537423612190053\ \(0\)\
\-\ therapy\\:\\ 0\\.03514831994216328\ \(0\)\
\-\ who\\:\\ 0\\.034276437063718496\ \(0\)\
\-\ metastatic\\:\\ 0\\.03309399082486293\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.032309769809720265\ \(0\)\
\-\ surgery\\:\\ 0\\.031923062528619615\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.03168845387664989\ \(0\)\
\-\ into\\:\\ 0\\.03128194412245703\ \(0\)\
\-\ associated\\:\\ 0\\.031022500952426185\ \(0\)\
\-\ woman\\:\\ 0\\.030367737653675484\ \(0\)\
\-\ disease\\:\\ 0\\.02148826986485699\ \(0\)\
\-\ history\\:\\ 0\\.018157146733955132\ \(0\)\
\-\ right\\:\\ 0\\.01387125706323718\ \(0\)\
\-\ \\(\\:\\ 0\\.011113257326828625\ \(0\)\
\-\ and\\:\\ 0\\.011077477275828829\ \(0\)\
\-\ \\)\\:\\ 0\\.01097750295558931\ \(0\)\
\-\ in\\:\\ 0\\.0064830343098500765\ \(0\)\
\-\ a\\:\\ 0\\.006101535412593866\ \(0\)\
\-\ \\,\\:\\ 0\\.004164770238727499\ \(0\)\
\-\ with\\:\\ 0\\.0036001284950735305\ \(0\)\
\-\ of\\:\\ 0\\.003584732332245798\ \(0\)\
\-\ \\.\\:\\ 0\\.002184586836759771\ \(0\)\
